Microbix Presenting at the 2024 Bloom Burton Conference

by Microbix | Apr 11, 2024 | News Releases

MISSISSAUGA, CANADA, April 11, 2024 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces it will be attending and presenting at the Bloom Burton & Co. Healthcare Investor Conference (the...

Episode 3: Diagnostics: Beyond the lab – Self-Collection with Copan Italia

by Microbix | Apr 2, 2024 | Media Featured Podcast

Microbix Announces Annual and Special Meeting Voting Results

by Microbix | Apr 1, 2024 | Blog, News Releases

MISSISSAUGA, April 1, 2024 – Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF) (“Microbix®” or the Company”), a life sciences innovator and exporter, announces the voting results from the Annual and Special Meeting of Shareholders of the Company (the “Meeting”)...

Microbix’s Clot-Buster Drug Project Advances

by Microbix | Mar 15, 2024 | News Releases

Sequel Pharma Executes Agreement with CDMO for Drug Substance Production MISSISSAUGA, CANADA, March 14, 2024 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that its funding and...

Microbix Unveils Test Controls for Head and Neck Cancer

by Microbix | Mar 11, 2024 | News Releases

HPV-related Tissue-Sample Mimics for QC of histology and PCR analyses MISSISSAUGA, CANADA, March 11, 2024 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it is presenting results of...